The increase in Fe2+stoichiometry caused the formation of side product 9 and 11 even formation of reduced alcohol products (12-15) by Minisci reaction.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:We aimed the synthesis of carboxamide 8 and10, however, beside the main product, one more species was detected in the reaction solution.
📊
Temel Bulgular & Veri:To establish reaction conditions for the synthesis of carboxamide derivatives, we have set upseveralexperiments by changing the Fe2+stoichiometry.
💡
Sonuç & Katkı:The increase in Fe2+stoichiometry caused the formation of side product 9 and 11 even formation of reduced alcohol products (12-15) by Minisci reaction.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
We aimed the synthesis of carboxamide 8 and10, however, beside the main product, one more species was detected in the reaction solution. The characterization of this side product showed that it was the other isomer of the main product. To establish reaction conditions for the synthesis of carboxamide derivatives, we have set upseveralexperiments by changing the Fe2+stoichiometry. When a molarequivalent Fe2+was used, only tworeaction products8 and 10wereobtained. The increase in Fe2+stoichiometry caused the formation of side product 9 and 11 even formation of reduced alcohol products (12-15) by Minisci reaction.
🔖
Bu Makaleye Atıf Yap
ÖZGERİŞ, B., TÜMER, F. (2019). A study of Minisci reaction by changing Fe2+equivalency: Preparation of arylpyridinyl methanol. Organic Communications, Cilt: 12 - Sayı: 3, 143–148. https://ajindex.com/articles/288462
Takemoto, M.; Yamamoto, Y.; and Achiwa, K.Effect of inhibitor or immobilization on reduction of benzoylpyridines by baker’s yeast. Chem. Pharm. Bull.1996, 44(4), 853-855. [2]Meguro, K.; Aizawa, M.; Sohda, T.; Kawamatsu, A.; Nagaoka, A. New 1, 4-Dihydropyridine derivatives with potent and long-lasting hypotensive effect. Chem. Pharm. Bull. 1985, 33, 3787. [3]Toda, F.; Tanaka, K.; Koshiro, K. A new preparative method for optically active diarylcarbinols. Tetrahedron: Asymm.1991, 2, 873-874. [4]Stanev, S.; Rakovska, R.; Berova, N.; Snatzke, G. Synthesis, absolute configuration and circular dichroism of some diarylmethane derivatives. Tetrahedron: Asymm.1995, 6, 183-198. [5] Botta, M.; Summa, V.; Corelli, F.; Di Pietro, G.; Lombardi, P. Synthesis of aryl 2-benzofuranyl and aryl 2-indolyl carbinols of high enantiomeric purity via palladium-catalyzed heteroannulation of chiral arylpropargylic alcohols. Tetrahedron: Asymm.1996,7, 1263-1266. [6]Bolshan, K.; Chen, C.-Y.; Chilenski, J. R.; Gosselin, F.; Mathre, D. J.; O_Shea, P. D.; Roy, A.; Tillyer, R. D. Nucleophilic displacement at benzhydryl centers: asymmetric synthesis of 1,1-diarylalkyl derivatives. Org. Lett. 2004, 6 (1), 111-114. [7] Schmidt, F.; Stemmler, R. T.; Rudolph, J.; Bolm, C. Catalytic asymmetric approaches towards enantiomerically enriched diarylmethanols and diarylmethylamines. Chem. Soc. Rev. 2006, 35, 454-470. [8]Murray, M.; Sefton, R.M.; Martini, R.; Butler, A.M. Comparative induction of CYP3A and CYP2B in rat liver by 3-benzoylpyridine and metyrapone. Chem. Biol. Interact.1998, 113, 161-173. [9]Harms, A. F.; Nauta, W. T. The effects of alkyl substitution in drugs-I. Substituted dimethylaminoethyl benzhydryl ethers. J. Med. Pharm. Chem. 1960, 2(1),57–77. [10] Sperber, N.; Papa, D.; Schwenk, E.; Sherlock, M. Pyridyl-substituted alkamine ethers as antihistaminic agents. J. Am. Chem. Soc. 1949, 71, 887–890. [11] Kawabata,T.; Ogino, T.; Mori, M.; Awai, M.Effect of nicotinamide and its isomers on iron-induced renal damage. Acta Pathol. Jpn. 1992, 42, 469–475. [12]Kuca, K.; Bielavsky, J.; Cabal, J.; Bielavska, M.Synthesis of a potential reactivator of acetylcholinesterase-1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)propane dibromide. Tetrahedron Lett. 2003, 44, 3123-3125. [13]Jeong, H.C.; Park, N.-J.; Chae, C.H.; Musilek, K.; Kassa, J.; Kuca, K.;. Jung, Y.-S. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterasesinhibited by paraoxon organophosphorus agent